The approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely adding to the massive demand for weight loss drugs like Wegovy and Ozempic.
The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
FDA approves new diabetes drug Mounjaro for weight loss wach.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wach.com Daily Mail and Mail on Sunday newspapers.
Zepbound: FDA approves new version of diabetes drug Mounjaro for weight loss wsbradio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsbradio.com Daily Mail and Mail on Sunday newspapers.